Targeted Substance Delivery for Brown Adipose Tissue Activation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating obesity, including surgical procedures and pharmaceutical approaches, are limited in effectiveness and often result in undesirable side effects, and there is a need for improved methods to activate brown adipose tissue (BAT) to increase energy expenditure and metabolic function.
Innovation Solution
The development of methods and devices for targeted substance delivery to activate brown adipose tissue, involving the use of chemicals that interact with cellular receptors, such as menthol, and delivery systems that can be activated by various triggers, including eating, temperature, and weight changes, to increase energy expenditure without surgical intervention.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If surgical procedures are used to treat obesity, then weight loss can be achieved, but complications, pain, scarring, and lengthy recovery periods occur
Solution Approach 1:
The patent replaces mechanical surgical intervention with chemical substance delivery. Instead of physically altering the stomach or intestines through surgery, the invention uses chemicals delivered via various routes (oral, transdermal, injection) to activate brown adipose tissue and increase energy expenditure, thereby treating obesity without surgical complications
Solution Approach 2:
The patent introduces brown adipose tissue (BAT) as an intermediary mechanism. The chemicals do not directly cause weight loss but instead activate BAT, which then increases energy expenditure and metabolism. This intermediary approach provides a safer alternative to direct surgical intervention while achieving the desired weight loss effect
2Use of energy by moving object
If pharmaceutical approaches are used to increase energy expenditure, then metabolic function can be improved, but technical and physiological limitations occur
Solution Approach 1:
The patent employs multiple chemicals with different properties and delivery methods to activate brown adipose tissue. By varying the chemical parameters (type, concentration, delivery route, timing), the invention overcomes the limitations of single-pharmaceutical approaches and achieves more versatile and effective energy expenditure enhancement
Solution Approach 2:
The patent divides the treatment approach into multiple components: different chemicals (e.g., menthol, capsaicin, norepinephrine), different delivery routes (oral, transdermal, injection), and different activation triggers (temperature, eating, weight changes). This segmented approach allows for more precise and adaptable treatment compared to single-pharmaceutical methods
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These methods and devices effectively activate BAT, leading to increased energy expenditure, weight loss, and improved metabolic function, providing a non-surgical alternative for obesity treatment and metabolic disorders like diabetes, without the risks associated with traditional surgical procedures.
Implementation Method 1
The chemical can be configured to chemically interact with cellular surface receptors of the brown adipose tissue
Implementation Method 2
When activated, BAT removes free fatty acids (FFA) and oxygen from the blood supply for the generation of heat. The oxidative phosphorylation cycle that occurs in the mitochondria of activated BAT
Data Source
AI summary
Methods and devices are provided for activating brown adipose tissue with targeted substance delivery. Generally, the methods and devices can activate BAT to increase thermogenesis, e.g., increase heat production in the patient, which over time can lead to weight loss and/or improved metabolic function. In one embodiment, a chemical configured to stimulate nerves that activate the BAT and/or to stimulate brown adipocytes directly can be delivered to a patient, thereby increasing thermogenesis in the BAT and inducing weight loss and/or improved metabolic function through energy expenditure. The chemical can be delivered to the patient locally and/or systemically to stimulate the nerves and/or the brown adipocytes.